國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Colon cancer diagnosis and therapy.V...

Nagaraju, Ganji Purnachandra.

Colon cancer diagnosis and therapy.Volume 1

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Colon cancer diagnosis and therapy.edited by Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma.
其他作者:	Nagaraju, Ganji Purnachandra.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	xii, 369 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Colon (Anatomy)Cancer
電子資源:	https://doi.org/10.1007/978-3-030-63369-1
ISBN:	9783030633691$q(electronic bk.)

Colon cancer diagnosis and therapy.Volume 1
Colon cancer diagnosis and therapy.Volume 1[electronic resource] /edited by Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma. - Cham :Springer International Publishing :2021. - xii, 369 p. :ill., digital ;24 cm.

Epidimology of colorectal cancer -- Colorectal cancer: A model for the study of cancer immunology -- Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients: An Emphasis on Colorectal Cancer -- Potential role of NMR and MRI in colon cancer -- Role of micro-RNA in-situ hybridization in colon cancer diagnosis -- Role of epigenetics in colorectal cancer -- Exosomal biomarkers in colorectal cancer -- Biomarkers as putative therapeutic targets in colorectal cancer -- Proteins involved in colorectal cancer: Identification strategies and possible roles -- Short-chain fatty acids as therapeutic agents in colon malignancies -- Targeting of angiogenesis for colorectal cancer therapy -- Anti-inflammatory molecular mechanism and contribution of drug transport molecules in colorectal cancer cells -- Emerging role of circulating tumour DNA in treatment response prognosis in colon cancer -- Immuno-modulating mediators of colon cancer as immunotherapeutic: mechanism and potential -- Immune checkpoint inhibitors as armor for targeted immunotherapy of colorectal cancer -- Examining the role of the MACC1 gene in colorectal cancer metastasis -- Index.

Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.

ISBN: 9783030633691$q(electronic bk.)

Standard No.: 10.1007/978-3-030-63369-1doiSubjects--Topical Terms:

512228
Colon (Anatomy)
--Cancer

LC Class. No.: RC280.C6 / .C65 2021

Dewey Class. No.: 616.994347

Colon cancer diagnosis and therapy.Volume 1
LDR:03515nmm a2200325 a 4500 001 601805
003 DE-He213
005 20210618070643.0
006 m d
007 cr nn 008maaau
008 211112s2021 sz s 0 eng d
020 $a 9783030633691$q(electronic bk.)
020 $a 9783030633684$q(paper)
024 7 $a 10.1007/978-3-030-63369-1 $2 doi
035 $a 978-3-030-63369-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.C6 $b .C65 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994347 $2 23
090 $a RC280.C6 $b .C719 2021
245 0 0 $a Colon cancer diagnosis and therapy. $n Volume 1 $h [electronic resource] / $c edited by Ganji Purnachandra Nagaraju, Dhananjay Shukla, Naveen Kumar Vishvakarma.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xii, 369 p. : $b ill., digital ; $c 24 cm.
505 0 $a Epidimology of colorectal cancer -- Colorectal cancer: A model for the study of cancer immunology -- Impact of Covid-19 Pandemic on Gastro Intestinal Cancer Patients: An Emphasis on Colorectal Cancer -- Potential role of NMR and MRI in colon cancer -- Role of micro-RNA in-situ hybridization in colon cancer diagnosis -- Role of epigenetics in colorectal cancer -- Exosomal biomarkers in colorectal cancer -- Biomarkers as putative therapeutic targets in colorectal cancer -- Proteins involved in colorectal cancer: Identification strategies and possible roles -- Short-chain fatty acids as therapeutic agents in colon malignancies -- Targeting of angiogenesis for colorectal cancer therapy -- Anti-inflammatory molecular mechanism and contribution of drug transport molecules in colorectal cancer cells -- Emerging role of circulating tumour DNA in treatment response prognosis in colon cancer -- Immuno-modulating mediators of colon cancer as immunotherapeutic: mechanism and potential -- Immune checkpoint inhibitors as armor for targeted immunotherapy of colorectal cancer -- Examining the role of the MACC1 gene in colorectal cancer metastasis -- Index.
520 $a Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis. This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coverage also addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effective management of colon cancer.
650 0 $a Colon (Anatomy) $x Cancer $x Diagnosis. $3 512228
650 0 $a Colon (Anatomy) $x Cancer $x Treatment. $3 710579
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Immunology. $3 189152
650 2 4 $a Biomedicine, general. $3 853300
700 1 $a Nagaraju, Ganji Purnachandra. $3 798639
700 1 $a Shukla, Dhananjay. $3 897344
700 1 $a Vishvakarma, Naveen Kumar. $3 897343
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-63369-1
950 $a Biomedical and Life Sciences (SpringerNature-11642)